Literature DB >> 17627303

A public T cell clonotype within a heterogeneous autoreactive repertoire is dominant in driving EAE.

Juscilene S Menezes1, Peter van den Elzen, Jordan Thornes, Donald Huffman, Nathalie M Droin, Emanual Maverakis, Eli E Sercarz.   

Abstract

Experimental autoimmune encephalomyelitis (EAE) is an animal model of multiple sclerosis. Immunization of B10.PL mice with the Ac1-9 peptide, the immunodominant determinant of myelin basic protein (MBP), produced a single episode of EAE followed by recovery and resistance to reinduction of disease. Using the CDR3 length spectratyping technique, we characterized the clonal composition of the Ac1-9-specific T cell repertoire from induction through onset and resolution of disease. Two clonally restricted subsets within a heterogeneous self-reactive repertoire were found in mouse lymph nodes, spleen, and spinal cord soon after immunization, before any sign of EAE. These clonotypes, designated BV8S2/BJ2S7 and BV16/BJ2S5, were present in all mice examined and thus considered public. BV8S2/BJ2S7 was found in far greater excess; was exclusively Th1 polarized; disappeared from the spinal cord, spleen, and lymph nodes concomitantly with recovery; and transferred disease to naive recipients. In contrast, BV16/BJ2S5 and numerous private clonotypes were either Th1 or Th2 and persisted following recovery. These results are consistent with the hypothesis that the public clonotype BV8S2/BJ2S7 is a driver of disease and necessary for its propagation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17627303      PMCID: PMC1906731          DOI: 10.1172/JCI28277

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  66 in total

1.  Migratory activity and functional changes of green fluorescent effector cells before and during experimental autoimmune encephalomyelitis.

Authors:  A Flügel; T Berkowicz; T Ritter; M Labeur; D E Jenne; Z Li; J W Ellwart; M Willem; H Lassmann; H Wekerle
Journal:  Immunity       Date:  2001-05       Impact factor: 31.745

2.  A kinetic basis for T cell receptor repertoire selection during an immune response.

Authors:  P A Savage; J J Boniface; M M Davis
Journal:  Immunity       Date:  1999-04       Impact factor: 31.745

3.  Limited clonality in autoimmunity: drivers and regulators.

Authors:  Peter van den Elzen; Juscilene S Menezes; Akio Ametani; Emanual Maverakis; Loui Madakamutil; Xiao-lei Tang; Vipin Kumar; Eli E Sercarz
Journal:  Autoimmun Rev       Date:  2004-11       Impact factor: 9.754

Review 4.  CD4+ Tregs and immune control.

Authors:  Zoltán Fehérvari; Shimon Sakaguchi
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808

5.  Control of experimental autoimmune encephalomyelitis by T cells responding to activated T cells.

Authors:  A W Lohse; F Mor; N Karin; I R Cohen
Journal:  Science       Date:  1989-05-19       Impact factor: 47.728

6.  CD62L is required on effector cells for local interactions in the CNS to cause myelin damage in experimental allergic encephalomyelitis.

Authors:  I S Grewal; H G Foellmer; K D Grewal; H Wang; W P Lee; D Tumas; C A Janeway; R A Flavell
Journal:  Immunity       Date:  2001-03       Impact factor: 31.745

7.  A common TCR V-D-J sequence in V beta 13.1 T cells recognizing an immunodominant peptide of myelin basic protein in multiple sclerosis.

Authors:  J Hong; Y C Zang; M V Tejada-Simon; M Kozovska; S Li; R A Singh; D Yang; V M Rivera; J K Killian; J Z Zhang
Journal:  J Immunol       Date:  1999-09-15       Impact factor: 5.422

8.  Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy.

Authors:  J L Urban; V Kumar; D H Kono; C Gomez; S J Horvath; J Clayton; D G Ando; E E Sercarz; L Hood
Journal:  Cell       Date:  1988-08-12       Impact factor: 41.582

9.  The composition of a primary T cell response is largely determined by the timing of recruitment of individual T cell clones.

Authors:  P Bousso; J P Levraud; P Kourilsky; J P Abastado
Journal:  J Exp Med       Date:  1999-05-17       Impact factor: 14.307

10.  Evolution of antigen-specific T cell receptors in vivo: preimmune and antigen-driven selection of preferred complementarity-determining region 3 (CDR3) motifs.

Authors:  L J McHeyzer-Williams; J F Panus; J A Mikszta; M G McHeyzer-Williams
Journal:  J Exp Med       Date:  1999-06-07       Impact factor: 14.307

View more
  28 in total

1.  T cell clonal expansions detected in patients with primary biliary cirrhosis express CX3CR1.

Authors:  Weici Zhang; Yoko Ono; Yoshinori Miyamura; Christopher L Bowlus; M Eric Gershwin; Emanual Maverakis
Journal:  J Autoimmun       Date:  2011-06-01       Impact factor: 7.094

2.  Escape from highly effective public CD8+ T-cell clonotypes by HIV.

Authors:  Maria Candela Iglesias; Jorge R Almeida; Solène Fastenackels; David J van Bockel; Masao Hashimoto; Vanessa Venturi; Emma Gostick; Alejandra Urrutia; Linda Wooldridge; Mathew Clement; Stéphanie Gras; Pascal G Wilmann; Brigitte Autran; Arnaud Moris; Jamie Rossjohn; Miles P Davenport; Masafumi Takiguchi; Christian Brander; Daniel C Douek; Anthony D Kelleher; David A Price; Victor Appay
Journal:  Blood       Date:  2011-07-06       Impact factor: 22.113

3.  A requisite role for induced regulatory T cells in tolerance based on expanding antigen receptor diversity.

Authors:  Dipica Haribhai; Jason B Williams; Shuang Jia; Derek Nickerson; Erica G Schmitt; Brandon Edwards; Jennifer Ziegelbauer; Maryam Yassai; Shun-Hwa Li; Lance M Relland; Petra M Wise; Andrew Chen; Yu-Qian Zheng; Pippa M Simpson; Jack Gorski; Nita H Salzman; Martin J Hessner; Talal A Chatila; Calvin B Williams
Journal:  Immunity       Date:  2011-06-30       Impact factor: 31.745

4.  CD4+ virtual memory: Antigen-inexperienced T cells reside in the naïve, regulatory, and memory T cell compartments at similar frequencies, implications for autoimmunity.

Authors:  Alina I Marusina; Yoko Ono; Alexander A Merleev; Michiko Shimoda; Hiromi Ogawa; Elizabeth A Wang; Kayo Kondo; Laura Olney; Guillaume Luxardi; Yoshinori Miyamura; Tilahun D Yilma; Itzel Bustos Villalobos; Jennifer W Bergstrom; Daniel G Kronenberg; Athena M Soulika; Iannis E Adamopoulos; Emanual Maverakis
Journal:  J Autoimmun       Date:  2016-11-25       Impact factor: 7.094

5.  Structural basis for enabling T-cell receptor diversity within biased virus-specific CD8+ T-cell responses.

Authors:  E Bridie Day; Carole Guillonneau; Stephanie Gras; Nicole L La Gruta; Dario A A Vignali; Peter C Doherty; Anthony W Purcell; Jamie Rossjohn; Stephen J Turner
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-23       Impact factor: 11.205

6.  Peptide-MHC class II complex stability governs CD4 T cell clonal selection.

Authors:  Christina K Baumgartner; Andrea Ferrante; Mika Nagaoka; Jack Gorski; Laurent P Malherbe
Journal:  J Immunol       Date:  2009-12-09       Impact factor: 5.422

7.  A translatable molecular approach to determining CD8 T-cell epitopes in TMEV infection.

Authors:  Jeremiah McDole; Georgette Suidan; Erin Boespflug; Jie Cheng; Yi Chen; Istvan Pirko; Aaron Johnson
Journal:  Hum Immunol       Date:  2008-09-24       Impact factor: 2.850

8.  Accelerated course of experimental autoimmune encephalomyelitis in PD-1-deficient central nervous system myelin mutants.

Authors:  Antje Kroner; Nicholas Schwab; Chi Wang Ip; Sonja Ortler; Kerstin Göbel; Klaus-Armin Nave; Mathias Mäurer; Rudolf Martini; Heinz Wiendl
Journal:  Am J Pathol       Date:  2009-05-14       Impact factor: 4.307

9.  Preferential Use of Public TCR during Autoimmune Encephalomyelitis.

Authors:  Yunqian Zhao; Phuong Nguyen; Jing Ma; Tianhua Wu; Lindsay L Jones; Deqing Pei; Cheng Cheng; Terrence L Geiger
Journal:  J Immunol       Date:  2016-05-11       Impact factor: 5.422

10.  Chromatin conformation governs T-cell receptor Jβ gene segment usage.

Authors:  Wilfred Ndifon; Hilah Gal; Eric Shifrut; Rina Aharoni; Nissan Yissachar; Nir Waysbort; Shlomit Reich-Zeliger; Ruth Arnon; Nir Friedman
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.